• Join
  • Login
  • Contact

Search abstracts

Elderly Patient‘s Access to Innovation -
Parallel Path Strategy and Clinical Data alongside the Product‘s Lifecycle

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: HOLBEIN, Baerbel (University of Bremen, IION, Lilienthal, Germany)
  • Co-author(s): Bärbel Holbein: IION, University of Bremen, Bremen, Germany
  • Abstract:


    Healthcare systems need to ensure medication are available for all patient populations, particularly for the fastest growing group of elderly patients. The development of innovative drugs, particularly for the treatment of the 65+ population, is risky, costly and highly complex. Within pharmaceutical economics, the theory of parallel..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses